Cannabis' Impact on Alcohol Consumption
Sponsor: Brown University • ClinicalTrials.gov ID: NCT05389930
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
This study employs a repeated measures experimental design to examine the effect of THC-dominant dose of cannabis and CBD-dominant dose of cannabis, relative to placebo, on subsequent drinking in an alcohol choice task in which participants choose either to drink or receive monetary reinforcement for drinks not consumed. Cannabis will be administered simultaneously with an alcohol-priming dose or alcohol placebo. The study will enroll up to 350 nontreatment-seeking heavy episodic alcohol drinkers who use cannabis weekly.
Interventions
-
THC-dominant cannabis
(Drug)
Smoked cannabis with 9.53% THC and 0.09% CBD
-
CBD-dominant cannabis
(Drug)
Smoked cannabis with 0.35% THC and 11.27% CBD
-
Cannabis placebo
(Drug)
Smoked placebo cannabis plant material
-
Alcohol
(Drug)
Drink containing 0.3 g/kg of alcohol
-
Alcohol placebo
(Drug)
Placebo beverage contains only juice and a negligible trace of alcohol for masking
Eligibility criteria
Conditions
Locations
- Brown University — Providence, Rhode Island, United States
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record